Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

n concurrently with ORENCIA(R) (abatacept) or within three months of its discontinuation as it may blunt the effectiveness of some immunizations. It is recommended that JIA patients be brought up to date with all immunizations in agreement with current immunization guidelines prior to initiating therapy with ORENCIA.

Use in Patients with Chronic Obstructive Pulmonary Disease (COPD): Adult COPD patients treated with ORENCIA developed adverse events more frequently than those treated with placebo (97 percent vs. 88 percent, respectively). Respiratory disorders occurred more frequently in patients treated with ORENCIA compared to those on placebo (43 percent vs. 24 percent, respectively), including COPD exacerbations, cough, rhonchi and dyspnea. A greater percentage of patients treated with ORENCIA developed a serious adverse event compared to those on placebo (27 percent vs. six percent), including COPD exacerbation [three of 37 patients (eight percent)] and pneumonia [one of 37 patients (three percent)]. Use of ORENCIA in patients with RA and COPD should be undertaken with caution, and such patients monitored for worsening of their respiratory status.

Blood Glucose Testing: ORENCIA contains maltose, which may result in falsely elevated blood glucose readings on the day of infusion when using blood glucose monitors with test strips utilizing glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ). Consider using monitors and advising patients to use monitors that do not react with maltose, such as those based on glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), glucose oxidase or glucose hexokinase test methods.

Pregnant and Nursing Mothers: ORENCIA should be used during pregnancy only if clearly needed. The risk for development of autoimmune diseases in humans exposed in utero to abatacept has not been determined. Nursing mothers should be informed of the risk/benefit of continued breast-feeding or discontinuation of the drug. A preg
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... ANGELES , July 23, 2014  Researchers from ... with calcium elevates calcium levels too high, ... among other health problems. Women close to ... and vitamin D to prevent diseases such as osteoporosis, ... would recommend that women determine how much calcium they ...
(Date:7/23/2014)... BOSTON , July 23, 2014  The ... CBRX ) will hold a conference call ... for the second quarter ended June 30, 2014. ... July 31, 2014Time: , 8:30 am EDTDial-in numbers: ... (Canada) or,International: (412) 317-0790Webcast (live & archive): , ...
(Date:7/23/2014)... , July 23, 2014  Cardica, Inc. (Nasdaq: ... for its fiscal fourth quarter and year ended June 30, ... Cardica,s management will host a conference call at 4:30 p.m. ... update on the company,s business. Conference Call Details ... at 4:30 p.m. Eastern Time via phone, please dial 866-953-6859 ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 2Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2
... Evergreen Hospital – one of the region,s leaders in ... gallbladder removal in the Washington and Oregon region on ... a procedure just approved by the FDA. ... two patients – a 66-year-old man and a 33-year-old ...
... March of Dimes announced today that Watson Pharmaceuticals has become ... the March of Dimes number one fundraising event, and will ... the organizations will also work to raise awareness of risk ... participating in March for Babies events around the country as ...
Cached Medicine Technology:Evergreen Hospital to Perform Region's First Single-Incision Gallbladder Removal 2Evergreen Hospital to Perform Region's First Single-Incision Gallbladder Removal 3Watson Partners With March of Dimes to Help Fight Preterm Birth 2
(Date:7/23/2014)... By using brightly hued dyes, George Mason University ... proteins touch each other, possibly leading to new ... lung disease. , George Mason researchers unraveled the ... touch each other. "One protein interlocks with another ... and this sends a signal down the line ...
(Date:7/23/2014)... Boston, MA (PRWEB) July 23, 2014 ... software technologies, the leasing and financing company LeaseQ ... in the server based software sector, they still ... sectors. , To learn more about technology ... Tirey, Founder and CEO of LeaseQ was quoted ...
(Date:7/23/2014)... 23, 2014 Splashtop , ... announce that it has joined the RSA Ready ... Splashtop Enterprise and RSA SecurID® multi-factor authentication solution ... , Splashtop also announced that leading ... deploying Splashtop Enterprise, the industry‚Äôs only on-premise remote ...
(Date:7/23/2014)... joined together for the first time to call for ... people worldwide suffering from the condition. , Psoriatic arthritis ... joint damage if left untreated. , PsA tends to ... a red, scaly rash, and affects approximately two per ... one in five go on to develop PsA ...
(Date:7/23/2014)... 2014 On July 21, 2014, My Positive ... Jack Tracey for an episode that spoke about the group ... asks Tracey to talk some about the formation of the ... mission, it was started right here in Charleston, originally it ... to help survivors of sexual abuse. Their purpose has shifted ...
Breaking Medicine News(10 mins):Health News:Researchers unlock the protein puzzle 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 2Health News:LeaseQ Announces That Although Software Investment Remains Sluggish, Technology Equipment Leasing Demand Remains Robust 3Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2
... ... voice of the stem cell revolution, is on a 10 city speaking/book tour including Spokane. ... ... interest in the stem cell phenomenon made a science book an overnight Amazon Best Seller ...
... , ... ... ... , ...
... ... ... ... ...
... Ill. -- Loyola University Medical Center ranked among ... research competition for pathologists in training. Loyola was ... of scientific studies accepted in the Stowell-Orbison Awards competition ... Pathology (USCAP). One hundred academic programs worldwide participated in ...
... doors, expert says , FRIDAY, Feb. 19 (HealthDay News) -- ... pediatric amputations due to trauma in the United States in ... found that there were more than 950 cases of traumatic ... children aged 4 and younger, amputations due to being caught ...
... treatments for blindness, researchers say , FRIDAY, Feb. 19 (HealthDay ... to see color than humans, a new study finds. , ... chicken,s eye and found that the receptors are arranged in ... colors in any part of the retina, the light-sensing structure ...
Cached Medicine News:Health News:Health: Surprise Best Seller is Stem Cell Book – Author in Spokane - 10 City Tour 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 3Health News:Medicare Advantage Members May Make Changes During Open Enrollment 2Health News:Medicare Advantage Members May Make Changes During Open Enrollment 3Health News:Traumatic Amputations in Children Have High Costs 2Health News:Chickens May Provide Clues to Color Vision 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
Medicine Products: